Allen Andrew R

• Director at Adaptimmune Therapeutics PLC · on record since Jun 1, 2023
• PRESIDENT AND CEO at Gritstone Oncology, Inc. · on record since Sep 27, 2018
• Chief Medical Officer, EVP at PHARMION CORP · on record since Dec 8, 2006
• Director at Cullinan Therapeutics, Inc. · on record since Aug 8, 2025
• See Remarks at Clovis Oncology, Inc. · on record since Feb 15, 2013
• Director at Epizyme, Inc. · on record since Jun 11, 2014
• Director at ProNAi Therapeutics Inc · on record since Oct 25, 2017
• Director at Gritstone Oncology, Inc. · on record since Sep 27, 2018
• Director at TCR2 THERAPEUTICS INC. · on record since Feb 13, 2019
• 10% owner at ProNAi Therapeutics Inc · on record since Jul 1, 2022